Charles River Laboratories Inter (NYSE: CRL) has reported E.P.S. of $1.34 for its third fiscal quarter (ending September 30) versus $1.70 for the same period a year ago — a decline of -21%. For the latest four quarters through September 30, E.P.S. were $8.04 compared to $9.30 a year ago — a decline of -14%.
Recent Price Action
Charles River Laboratories Inter (NYSE: CRL) stock closed at $214.20 on 11/6/24 after a major increase of 13.5%. Moreover, trading volume in this advance was exceptionally high at 321% of normal. Relative to the market the stock has been weak over the last nine months but has risen 16.4% during the last week.
Current PriceTarget Research Rating
Reflecting future returns on capital that are forecasted to be above the cost of capital, CRL is expected to continue to be an important Value Builder.
Charles River Laboratories Inter has a current Value Trend Rating of D (Negative). With this rating, PTR’s two proprietary measures of a stock’s current attractiveness are providing very contradictory signals. Charles River Laboratories Inter has a slightly positive Appreciation Score of 64 but a very low Power Rating of 13, leading to the Negative Value Trend Rating.
Rating Review
In light of this new information and very positive price change we are reviewing our current Overall Rating of D. This review will be completed in the next several days.
Be the first to comment